Annual Non Current Assets
$10.00 K
-$321.00 K-96.98%
December 31, 2024
Summary
- As of March 8, 2025, SYRE annual long term assets is $10.00 thousand, with the most recent change of -$321.00 thousand (-96.98%) on December 31, 2024.
- During the last 3 years, SYRE annual non current assets has fallen by -$11.03 million (-99.91%).
- SYRE annual non current assets is now -99.92% below its all-time high of $11.83 million, reached on December 1, 2020.
Performance
SYRE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$10.00 K
$0.000.00%
December 31, 2024
Summary
- As of March 8, 2025, SYRE quarterly long term assets is $10.00 thousand, unchanged on December 31, 2024.
- Over the past year, SYRE quarterly non current assets has dropped by -$321.00 thousand (-96.98%).
- SYRE quarterly non current assets is now -99.92% below its all-time high of $12.61 million, reached on June 1, 2021.
Performance
SYRE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
SYRE Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.0% | -97.0% |
| 3 y3 years | -99.9% | -99.9% |
| 5 y5 years | -99.9% | -99.9% |
SYRE Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -99.9% | at low | -99.9% | at low |
| 5 y | 5-year | -99.9% | at low | -99.9% | at low |
| alltime | all time | -99.9% | -100.0% | -99.9% | at low |
Spyre Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $608.47 M(+78.2%) | $10.00 K(0.0%) |
| Sep 2024 | - | $10.00 K(-97.0%) |
| Jun 2024 | - | $331.00 K(+0.6%) |
| Mar 2024 | - | $329.00 K(-0.6%) |
| Dec 2023 | $341.53 M(+448.6%) | $331.00 K(-74.8%) |
| Sep 2023 | - | $1.32 M(-63.9%) |
| Jun 2023 | - | $3.64 M(-54.9%) |
| Mar 2023 | - | $8.08 M(-9.1%) |
| Dec 2022 | $62.26 M(-37.0%) | - |
| Dec 2022 | - | $8.89 M(-4.9%) |
| Sep 2022 | - | $9.35 M(-7.1%) |
| Jun 2022 | - | $10.06 M(-4.9%) |
| Mar 2022 | - | $10.57 M(-4.2%) |
| Dec 2021 | $98.89 M(-34.0%) | $11.04 M(-4.4%) |
| Sep 2021 | - | $11.55 M(-8.5%) |
| Jun 2021 | - | $12.61 M(+3.4%) |
| Mar 2021 | - | $12.20 M(+3.2%) |
| Dec 2020 | $149.79 M(+101.0%) | $11.83 M(+5.3%) |
| Sep 2020 | - | $11.23 M(+1.7%) |
| Jun 2020 | - | $11.04 M(+5.0%) |
| Mar 2020 | - | $10.52 M(+21.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $74.50 M(-2.8%) | $8.68 M(+16.2%) |
| Sep 2019 | - | $7.47 M(-1.2%) |
| Jun 2019 | - | $7.56 M(+344.4%) |
| Mar 2019 | - | $1.70 M(+59.3%) |
| Dec 2018 | $76.67 M(+39.4%) | $1.07 M(+19.3%) |
| Sep 2018 | - | $895.00 K(+8.5%) |
| Jun 2018 | - | $825.00 K(-12.5%) |
| Mar 2018 | - | $943.00 K(-13.2%) |
| Dec 2017 | $54.99 M(-17.2%) | $1.09 M(+10.5%) |
| Sep 2017 | - | $983.00 K(+4.5%) |
| Jun 2017 | - | $941.00 K(-2.2%) |
| Mar 2017 | - | $962.00 K(+50.5%) |
| Dec 2016 | $66.42 M(+73.5%) | $639.00 K(+67.3%) |
| Sep 2016 | - | $382.00 K(-3.3%) |
| Jun 2016 | - | $395.00 K(+16.5%) |
| Mar 2016 | - | $339.00 K(-7.9%) |
| Dec 2015 | $38.29 M(+1302.4%) | $368.00 K(-1.9%) |
| Sep 2015 | - | $375.00 K(+40.4%) |
| Jun 2015 | - | $267.00 K(+4.7%) |
| Mar 2015 | - | $255.00 K(+27.5%) |
| Dec 2014 | $2.73 M(-40.6%) | $200.00 K |
| Dec 2013 | $4.60 M | - |
FAQ
- What is Spyre Therapeutics annual long term assets?
- What is the all time high annual non current assets for Spyre Therapeutics?
- What is Spyre Therapeutics annual non current assets year-on-year change?
- What is Spyre Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly non current assets year-on-year change?
What is Spyre Therapeutics annual long term assets?
The current annual non current assets of SYRE is $10.00 K
What is the all time high annual non current assets for Spyre Therapeutics?
Spyre Therapeutics all-time high annual long term assets is $11.83 M
What is Spyre Therapeutics annual non current assets year-on-year change?
Over the past year, SYRE annual long term assets has changed by -$321.00 K (-96.98%)
What is Spyre Therapeutics quarterly long term assets?
The current quarterly non current assets of SYRE is $10.00 K
What is the all time high quarterly non current assets for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly long term assets is $12.61 M
What is Spyre Therapeutics quarterly non current assets year-on-year change?
Over the past year, SYRE quarterly long term assets has changed by -$321.00 K (-96.98%)